RichardFumitsuguArakakiMD

Endocrinology • Honolulu, HI

Diabetes, Lipid Metabolism

Professor, Medicine, University of Hawaii John A Burns School of Medicine

Join to view full profile

Dr. Arakaki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Arakaki's full profile

Already have an account?

Office
1356 Lusitana St
Fl 7
Honolulu, HI 96813
Is this information wrong?

Education & Training

Baylor College of MedicineResidency, Internal Medicine, 1982 - 1985
University of Hawaii, John A. Burns School of MedicineClass of 1982

Certifications & Licensure

HI State Medical License 1990 - 2026
CA State Medical License 2021 - 2025
MD State Medical License 1985 - 1990
TX State Medical License 1983 - 1985
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

Clinical Trials

Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
Active, not recruiting
Phase 3
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
Completed
Phase 3
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01
Terminated
Phase 2
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes Start of enrollment: 2014 Apr 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

30 citations
Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes.
Richard Arakaki> ;Postgraduate Medicine. 2016 Apr 4
15 citations
Psychosocial and Clinical Outcomes of a Cognitive Behavioral Therapy for Asians and Pacific Islanders with Type 2 Diabetes: A Randomized Clinical Trial.
Jillian Inouye, Dongmei Li, James Davis, Richard Arakaki> ;Hawai'i Journal of Medicine & Public Health. 2015 Nov 1
1 citations
Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort.
Kieren J. Mather, Qing Pan, William C. Knowler, Tohru Funahashi, George A. Bray, Richard Arakaki, Bonita Falkner, Kumar Sharma, Barry J. Goldstein> ;Plos One. 2015 Aug 27
43 citations
TWO TREATMENT APPROACHES FOR HUMAN REGULAR U-500 INSULIN IN PATIENTS WITH TYPE 2 DIABETES NOT ACHIEVING ADEQUATE GLYCEMIC CONTROL ON HIGH-DOSE U-100 INSULIN THERAPY WI...
Robert C. Hood, Richard Arakaki, Carol Wysham, Ying G. Li, Julie Settles, Jeffrey A. Jackson> ;Endocrine Practice. 2015 Mar 26
30 citations
Erratum. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabe...
Carol Wysham, Thomas Blevins, Richard Arakaki, Gildred Colon, Pedro Garcia, Charles Atisso, Debra Kuhstoss, Mark Lakshmanan> ;Diabetes Care. 2014 Oct 1
12 citations
Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program
Dana Dabelea, Yong Ma, William C. Knowler, Santica M. Marcovina, Christopher D. Saudek, Richard Arakaki, Neil H. White, Steven E. Kahn, Trevor J. Orchard, Ronald B. Go...> ;Diabetic Medicine. 2014 Sep 1
245 citations
Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)
Carol Wysham, Thomas Blevins, Richard Arakaki, Gildred Colon, Pedro Garcia, Charles Atisso, Debra Kuhstoss, Mark Lakshmanan> ;Diabetes Care. 2014 Aug 1
1 citations
Toxic multinodular goiter in a patient with end-stage renal disease and hemodialysis.
Edison So, Richard Arakaki> ;Hawai'i Journal of Medicine & Public Health. 2014 Jul 1
12 citations
Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a p...
Richard Arakaki, T. C. Blevins, J. K. Wise, D. R. Liljenquist, Honghua Jiang, Jennie G. Jacobson, Sherry Martin, Jeffrey A. Jackson> ;Diabetes, Obesity & Metabolism. 2014 Jun 1
3 citations
Ethnic differences and β-cell changes.
Richard Arakaki> ;The Journal of Clinical Endocrinology and Metabolism. 2013 Dec 16
5 citations
Associations between Psychosocial and Physiological Factors and Diabetes Health Indicators in Asian and Pacific Islander Adults with Type 2 Diabetes
Dongmei Li, Jillian Inouye, James Davis, Richard Arakaki> ;Nursing Research and Practice. 2013 Oct 24
62 citations
Lifestyle and Metformin Treatment Favorably Influence Lipoprotein Subfraction Distribution in the Diabetes Prevention Program
Ronald B. Goldberg, Marinella Temprosa, J Otvos, John D. Brunzell, Santica M. Marcovina, Kieren J. Mather, Richard Arakaki, Karol E. Watson, Edward S. Horton, Elizabet...> ;The Journal of Clinical Endocrinology and Metabolism. 2013 Aug 26
1 citations
Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal I...
Richard M. Bergenstal, Julio Rosenstock, Richard Arakaki, Melvin J. Prince, Yongming Qu, Vikram Sinha, Daniel C. Howey, Scott J. Jacober> ;Diabetes Care. 2013 Jul 1
102 citations
A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes.
Richard M. Bergenstal, Julio Rosenstock, Richard Arakaki, Melvin J. Prince, Yongming Qu, Vikram Sinha, Daniel C. Howey, Scott J. Jacober> ;Diabetes Care. 2012 Nov 1
11 citations
Impact of Race/ethnicity on Efficacy and Safety of Two Starter Insulin Regimens in Patients with Type 2 Diabetes: A Posthoc Analysis of the DURABLE Trial
Jaime A. Davidson, Bruce H. R. Wolffenbuttel, Richard Arakaki, A. Enrique Caballero, Honghua H. Jiang, Dana S. Hardin> ;Ethnicity & Disease. 2013 Jan 1
7 citations
Diabetic Ketoacidosis in Acromegaly: A Case Report
Pilaiporn Palakawong, Richard Arakaki> ;Endocrine Practice. 2012 Nov 27
34 citations
Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
Jose C. Florez, Kathleen A. Jablonski, Jarred B. McAteer, Paul W. Franks, Clinton C. Mason, Kieren J. Mather, Edward S. Horton, Ronald N. Goldberg, Dana Dabelea, Steve...> ;Plos One. 2012 Sep 11
26 citations
Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;Plos Genetics. 2012 Aug 1
Changes in Fasting Plasma Glucose Levels with Ribavirin and Pegylated Interferon Treatment in Normal and Impaired Glucose Tolerant Patients with Chronic Hepatitis C
Ongkarn Sarasombath, Nuntra Suwantarat, Alan D. Tice, Richard Arakaki> ;Hawai'i Journal of Medicine & Public Health. 2012 May 1
3 citations
Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs
Kathleen Dungan, John B. Buse, William H. Herman, Richard Arakaki, Honghua H. Jiang, Jennie G. Jacobson, Jessie L. Fahrbach> ;Diabetes Research and Clinical Practice. 2012 Jun 1
52 citations
Pathophysiologic Differences Among Asians, Native Hawaiians, and Other Pacific Islanders and Treatment Implications
William C. Hsu, Edward J. Boyko, Wilfred Y. Fujimoto, Alka M. Kanaya, Wahida Karmally, Andrew J. Karter, George L. King, Mele A. Look, Gertraud Maskarinec, Ranjita Mis...> ;Diabetes Care. 2012 May 1
4 citations
Perceptions Related to Diet and Exercise Among Asians and Pacific Islanders with Diabetes
Nafanua Braginsky, Jillian Inouye, Chen-Yen Wang, Richard Arakaki> ;Hawaii Medical Journal. 2011 Sep 1
8 citations
Concomitant oral antihyperglycemic agent use and associated treatment outcomes after initiation of insulin therapy.
William H. Herman, John B. Buse, Richard Arakaki, Kathleen Dungan, Honghua H. Jiang, Jennie G. Jacobson, Jessie L. Fahrbach> ;Endocrine Practice. 2011 May 6
34 citations
Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to a...
William F. Miser, Richard Arakaki, Honghua Jiang, Jamie Scism-Bacon, Pamela W. Anderson, Jessie L. Fahrbach> ;Clinical Therapeutics. 2010 May 1
9 citations
A 47, XXY patient and Xq21.31 duplication with features of Prader–Willi syndrome: results of array-based comparative genomic hybridization
Pornpoj Pramyothin, Manop Pithukpakorn, Richard Arakaki> ;Endocrine. 2010 Apr 9
Join now to see all

Grant Support

In Vitro Translation Study Of Human Insulin Receptor Fatty AcylationNational Institute Of General Medical Sciences1998–2001
In Vitro Translation Study Of Human Insulin Receptor Fatty AcylationNational Institute Of General Medical Sciences1996–1997
Insulin Sensitivity In Native Hawaiians With NIDDMNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1994

Hospital Affiliations

The Queen's Medical CenterHonolulu, Hawaii